A Phase I Study to Evaluate the Safety/Tolerability and Pharmacokinetics of TOP1288 Rectal Single and Multiple Ascending Doses in Healthy Subjects and Multiple Doses in Subjects With Ulcerative Colitis

Trial Profile

A Phase I Study to Evaluate the Safety/Tolerability and Pharmacokinetics of TOP1288 Rectal Single and Multiple Ascending Doses in Healthy Subjects and Multiple Doses in Subjects With Ulcerative Colitis

Completed
Phase of Trial: Phase I

Latest Information Update: 27 May 2017

At a glance

  • Drugs TOP 1288 (Primary)
  • Indications Ulcerative colitis
  • Focus Adverse reactions; First in man
  • Sponsors TopiVert
  • Most Recent Events

    • 24 May 2016 Results study of single and multiple ascending doses in healthy volunteers (n=61) presented at the Digestive Disease Week 2016
    • 10 May 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Jul 2016.
    • 09 May 2016 Results will be presented a the Digestive Disease Week (DDW) 2016, according to a TopiVert media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top